Related Experiment Video
Updated: May 12, 2026
Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
Published on: June 17, 2015
Amyloid-β oligomer synaptotoxicity is mimicked by oligomers of the model protein HypF-N
Francesca Tatini1, Anna Maria Pugliese, Chiara Traini
1Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy.
Abstract:
Protein misfolded oligomers are thought to be the primary pathogenic species in many protein deposition diseases. Oligomers by the amyloid-β peptide play a central role in Alzheimer's disease pathogenesis, being implicated in synaptic dysfunction. Here we show that the oligomers formed by a protein that has no link with human disease, namely the N-terminal domain of HypF from Escherichia coli (HypF-N), are also synaptotoxic. HypF-N oligomers were found to (i) colocalize with post-synaptic densities in primary rat hippocampal neurons; (ii) induce impairment of long-term potentiation in rat hippocampal slices; and (iii) impair spatial learning of rats in the Morris Water Maze test. By contrast, the native protein and control nontoxic oligomers had none of such effects. These results raise the importance of using HypF-N oligomers as a valid tool to investigate the pathogenesis of Alzheimer's disease, with advantages over other systems for their stability, reproducibility, and costs. The results also suggest that, in the context of a compromised protein homeostasis resulting from aggregation of the amyloid β peptide, a number of oligomeric species sharing common synaptotoxic activity can arise and cooperate in the pathogenesis of the disease.
Insights
Misfolded protein oligomers, like those from HypF-N, can be toxic to synapses. These oligomers impair neuronal function and spatial learning, offering a new tool for Alzheimer's disease research.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Protein misfolded oligomers are key in protein deposition diseases.
- Amyloid-beta (Aβ) oligomers are central to Alzheimer's disease (AD) pathogenesis and synaptic dysfunction.
Purpose of the Study:
- To investigate the synaptotoxicity of oligomers formed by the N-terminal domain of HypF from Escherichia coli (HypF-N).
- To assess the potential of HypF-N oligomers as a model system for studying Alzheimer's disease pathogenesis.
Main Methods:
- Primary rat hippocampal neuron cultures were used to assess oligomer colocalization with post-synaptic densities.
- Long-term potentiation (LTP) was measured in rat hippocampal slices.
- Spatial learning was evaluated in rats using the Morris Water Maze test.
Main Results:
- HypF-N oligomers colocalized with post-synaptic densities in hippocampal neurons.
- HypF-N oligomers induced impairment of long-term potentiation in hippocampal slices.
- HypF-N oligomers impaired spatial learning in rats, unlike native HypF-N or control oligomers.
Conclusions:
- HypF-N oligomers exhibit synaptotoxic effects, mirroring aspects of Alzheimer's disease pathogenesis.
- HypF-N oligomers represent a stable, reproducible, and cost-effective tool for studying synaptotoxicity and AD.
- Oligomeric species, even unrelated to human disease, can share common synaptotoxic activities and contribute to disease pathogenesis when protein homeostasis is compromised.
More Related Videos
04:41Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
Related Concept Videos
03:03Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...